Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease ; volume:12 ; number:1 ; day:2 ; month:1 ; year:2020 ; pages:1-7 ; date:12.2020
Alzheimer's research & therapy ; 12, Heft 1 (2.1.2020), 1-7, 12.2020

Urheber
Parbo, Peter
Madsen, Lasse Stensvig
Ismail, Rola
Zetterberg, Henrik
Blennow, Kaj
Eskildsen, Simon F.
Vorup-Jensen, Thomas
Brooks, David J.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13195-019-0574-0
URN
urn:nbn:de:101:1-2020041200415035104953
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:53 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Parbo, Peter
  • Madsen, Lasse Stensvig
  • Ismail, Rola
  • Zetterberg, Henrik
  • Blennow, Kaj
  • Eskildsen, Simon F.
  • Vorup-Jensen, Thomas
  • Brooks, David J.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Brainstem substructures and cognition in prodromal Alzheimer’s disease

Brainstem substructures and cognition in prodromal Alzheimer’s disease

Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease

Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease

Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians

Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians

EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features

EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features

A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease

A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial

Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease

Alzheimer’s Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer’s Disease

Alzheimer’s Disease Composite Score: a Post-Hoc Analysis Using Data from the LipiDiDiet Trial in Prodromal Alzheimer’s Disease

Verbundene Objekte